Athersys logo

Athersys

Committed to developing therapies to extend and enhance the quality of life.

37 employees · est. 1995 · Cleveland, United States

VS
BlueRock Therapeutics logo

BlueRock Therapeutics

Striving to transform the treatment of disease by harnessing the power of cell therapy

478 employees · est. 2016 · Cambridge, United States

Athersys is the older company (1995 vs 2016); BlueRock Therapeutics is the larger of the two.

Side-by-Side Comparison

Athersys BlueRock Therapeutics
Founded
1995 older 2016
Headquarters
Cleveland, United States Cambridge, United States
Employees
37 478 larger
Industry
Biopharma, Biotechnology, Health Care Biopharma, Biotechnology, Health Care
Funding Stage
Post Ipo Equity Acquired
Total Funding
$208.90M $1.23B
Funding Rounds
9 2
Services
Not tracked yet Development of Cell Therapies, Clinical Trial Management, Research and Development
Target Customers
Not tracked yet Patients with Degenerative Diseases, Healthcare Providers, Medical Researchers
Taxonomy
Biopharmaceutical, Therapeutics, Clinical Stage, Drug Development, Regenerative Medicine, Stem Cell Therapy, Pharmaceuticals, Innovation, Disease Indications, Clinical Trials, Proprietary Technologies, Life-threatening Diseases, Quality Of Life, Multi-disease Indications Cell Therapy, Clinical Stage Biotech, Neurological Diseases, Ophthalmic Diseases, Parkinson’s Disease, Photoreceptor Diseases, Induced Pluripotent Stem Cells (iPSC), Regenerative Medicine, Heart Muscle Regeneration, Myocardial Infarction Treatment, Chronic Heart Failure, Engineered Cell Therapy, Biopharmaceuticals, Stem Cell Therapeutics, Genome Medicine
Website
athersys.com bluerocktx.com
Athersys logo

About Athersys

Athersys is a biopharmaceutical company committed to developing therapies to extend and enhance the quality of life. Established in 1995 and headquartered in the United States, Athersys focuses on the discovery and development of innovative medicines to treat significant and life-threatening disease...

BlueRock Therapeutics logo

About BlueRock Therapeutics

BlueRock Therapeutics is a cutting-edge, clinical-stage cell therapy company dedicated to reshaping the landscape of disease treatment. Emphasizing the transformative potential of cell therapy, it has constructed a promising pipeline targeting severe neurological and ophthalmic conditions. Key clini...

We will tell you when either one moves

BounceWatch watches Athersys and BlueRock Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Athersys and BlueRock Therapeutics — by email.

Frequently Asked Questions

Athersys — Committed to developing therapies to extend and enhance the quality of life.. BlueRock Therapeutics — Striving to transform the treatment of disease by harnessing the power of cell therapy. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Athersys has raised $208.90M while BlueRock Therapeutics has raised $1.23B.
Athersys and BlueRock Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Athersys with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Athersys on 12 Sep 2024, and BlueRock Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy